Safety and efficacy of Transurethral Bipolar Enucleation of prostate (TUBE) in BPH

Mallikarjuna Reddy Nalubolu, Vedamurthy Reddy Pogula, Sivasankar Reddy Challa, Vijayabhaskar Reddy Gouru, Ranadheer byram, Sudeep Bodduluri, Harikrishna Maddiboina

Abstract


Objectives: To evaluate the safety and efficacy of transurethral bipolar enucleation of the prostate due to benign prostatic hyperplasia. Methods: This is a prospective study and 37 patients undergoing Transurethral bipolar enucleation of the prostate (TUBE) for BPH will be taken for the study. Preoperative factors evaluated included International Prostate Symptom Score (IPSS), postvoid residual volume (PVR), estimated blood loss, operative time, pathologic weight, and complications. Postoperative evaluation was performed at 1month, 6 months and 12months. Results: Preoperative, 1 month, 6 months, and 12 months mean postvoid residual volumes were 235 mL, 33.6 mL, 20 mL and 20 mL; mean IPSS were 31.6, 2.97, 2.97 and 2.97; mean Q max was 5.8ml/sec, 20.23ml/sec,25.5ml/sec, and 25.5ml/sec; preoperative and post operative mean quality of life scores were 5.4 and 2.2; mean operative time was 87.5 minutes. Hemoglobin drop was 0.6g/dl, and pathologic weight was 45.45 g. 10 patients underwent partial enucleation. Early stress incontinence occurred in 9 patients (24.3%). Urinary tract infection occurred in 1 patient, and Superficial mucosal bladder injury in 1 patient. Conclusions: International Prostate Symptom Score, quality of life, Qmax, and postvoid residual volume (PVR) showed statistically significant improvements from baseline. TUBE is a safe, effective, and reproducible procedure for BPH.

Full Text:

PDF HTML

References


Lee C, Kozlowski JM, Grayhack JT. Intrinsic and extrinsic factors controlling benign prostatic growth. Prostate. 1997 May 1; 31(2):131-8.

Auffenberg GB, Helfand BT, Mc Vary KT. Established medical therapy for benign prostatic hyperplasia. doi: 10.1016/j.ucl.2009.07.004.

Reynard JM. Does anticholinergic medication have a role for men with lower urinary tract symptoms/ benign prostatic hyperplasia either alone or in combination with other agents?

Curr Opin Urol. 2004 Jan;14(1):13-6.

Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in America project: benign prostatic hyperplasia. DOI: 10.1097/01.ju.0000155709.37840.fe

McConnell JD, Roehrborn CG, Bautista OM, et al. Medical Therapy of Prostatic Symptoms (MTOPS) Research Group. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. DOI: 10.1056/NEJMoa030656

Chacko KN, Donovan JL, Abrams P, et al. Peters TJ, Brookes ST, Thorpe AC, GujralS, Wright M, Kennedy LG, Neal DE. Transurethral prostatic resection or laser therapy for men with acute urinary retention: the Clas P randomized trial. J Urol. 2001 Jul; 166(1):166-70; discussion 170-1.

Madersbacher S, Marberger M. Is transurethral resection of the prostate still justified? BJU Int. 1999 Feb; 83(3):227-37.

Fraundorfer MR, Gilling P: holmium: YAG laser enucleation of the prostate combined with mechanical Morcellation: preliminary results. EUR Urol. 1998; 33 (1): 69-72.

Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention. DOI:10.1016/j.eururo.2005.12.042

Hirasawa Y, Kato Y, Fujita K. Transurethral Enucleation with Bipolar for BenignProstaticHyperplasia: 2-Year Outcomes and the Learning Curve of a Single Surgeon's Experience of 603 Consecutive Patients. doi: 10.1089/ end. 2017.0092. Epub 2017 May 25.

Hochreiter WW, Thalmann GN, Burkhard FC, Studer UE. Holmium laser enucleation of the prostate combined with electrocautery resection: the mushroom technique. J Urol 2002; 168(4):1470–1474.

Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention. DOI:10.1016/j.eururo.2005.12.042

Oelke M, Bachmann A, Descazeaud A, et al. Emberton M, Gravas S, Michel MC, N'dow J, Nordling J, de la Rosette JJ; European Association of Urology. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. doi: 10.1016/j. eururo. 2013.03.004. Epub 2013 Mar 13.

Freyer PJ. Total enucleation of the prostate: a further series of 550 cases of the operation. Br Med J. 1919 Feb 1;1 (3031): 121-120.2.

Gilling PJ, Kennett KM, Fraundorfer MR. Holmium laser enucleation of the prostate for glands larger than 100 g: an endourologic alternative to open prostatectomy. J Endourol 2000; 14:529-531.

Ahyai SA, Gilling P, Kaplan SA, et al. Kuntz RM, Madersbacher S, Montorsi F, Speakman MJ, Stief CG. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. doi: 10.1016/j.eururo. 2010. 06.005. Epub 2010 Jun 11.

Neill MG, Gilling PJ, Kennett KM, et al. Rando-mized trial comparing holmium laser enucleation of prostate with plasmakinetic enucleation of prostate for treatment of benign prostatic hyperplasia. Urology 2006; 68(5):1020-1024.

Neill MG, Gilling PJ, Kennett KM, et al. Frampton CM, Westenberg AM, Fraundorfer MR, Wilson LC. Randomized trial comparing holmiumlaser enucleation of prostate with plasmakineticenucleation of prostate for treatment of benign prostatic hyperplasia. DOI: 10. 1016/j. urology.2006.06.021

Liu C, Zheng S, Li H, Xu k. Transurethral enucleation and resection of prostate in patients with benign prostatic hyperplasia by plasma kinetics. J Urol 2010; 184 (6): 2440-2445. doi: 10.1016/j. juro. 2010. 08.037.

Fayad AS, Sheikh MG, Zakaria T, et al. Elfottoh HA, Alsergany R. Holmium laser enucleation versus bipolar resection of the prostate: a prospective rando-mized study. Which to choose?

doi: 10.1089/end.2011.0059. Epub 2011 Jul 11

Elshal AM, Elmansy HM, Elhilali MM. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH). doi: 10.1111/j.1464-410X.2012.11290.x.Epub 2012 Jun 15.

Zhao Z, Zeng G, Zhong W, et al. Mai Z, Zeng S, Tao X. A prospective, randomised trial comparing plasmakinetic enucleation to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: three-year follow-up results. doi: 10.1016/j.eururo.2010.08.026. Epub 2010 Aug 20.

Seki N, Mochida O, Kinukawa N, et al. Sagiyama K, Naito S. Holmium laser enucleation for prostatic adenoma: analysis of learning curve over the course of 70 consecutive cases. DOI:10.1097/01.ju.0000092035.16351.9d

Neill MG, Gilling PJ, Kennett KM, et al. Frampton CM, Westenberg AM, Fraundorfer MR, Wilson LC. Randomized trial comparing holmiumlaser enucleation of prostate with plasmakinetice nucleation of prostate for treatment of benign prostatic hyperplasia. DOI:10.1016/j.urology. 2006.06.021

Liu C, Zheng S, Li H, Xu K: Transurethral enucleation and resection of prostate in patients with benign prostatic hyperplasia by plasma kinetics. J Urol. 2010; 184 (6): 2440–2445. doi: 10.1016/j.juro. 2010. 08.037.

Liao N, Yu J. A study comparing plasmakinetic enucleation with bipolar plasmakinetic resection of the prostate for benign prostatic hyperplasia. DOI:10.1089/end.2011.0358


Refbacks

  • There are currently no refbacks.